Differences in the Glucose Management Indicator Between Continuous Glucose Monitoring Systems
Diabetes, Obesity and Metabolism · 05.11.2026
DOI: 10.1111/dom.71486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 05.11.2026. Verfasst von Katrine Bovién Gørlitz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Diagnostic Center, University Clinic for Innovative Patient Pathways, Regional Hospital Central Jutland, Silkeborg/Viborg, Denmark. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aim
The glucose management indicator (GMI) estimates HbA1c from continuous glucose monitoring (CGM)‐derived mean glucose. We assessed whether this relationship differs between contemporary CGM systems. Materials and Methods In this observational study, mean sensor glucose was derived from 2 months of CGM data preceding HbA1c measurement in adults with Type 1 diabetes using Dexcom (Dx) G6/G7 ( n = 252) or Medtronic Guardian 4/Simplera (GSi) ( n = 180). Device‐specific GMI equations were derived using linear regression of measured HbA1c on mean sensor glucose and compared with the original GMI equation. For direct comparison of the Dx and GSi GMI equations, these GMI equations were combined, with 95% confidence intervals calculated using the delta method.
Results
The Dx GMI equation yielded statistically significantly lower GMI values compared with the original GMI equation at mean sensor glucose levels < 13.7 mmol/L, with increasing differences at lower glucose levels. Conversely, at mean sensor glucose levels above 8.3 mmol/L, the GSi GMI equation yielded statistically significantly higher GMI values than the original GMI equation, with increasing differences at higher glucose levels. The Dx and GSi device‐specific GMI equations yielded statistically significantly different GMI values > 6.7 mmol/L, with increasing differences at higher glucose levels.
Conclusions
The relationship between mean sensor glucose and HbA1c differed between contemporary CGM systems. This finding suggests that device‐specific GMI equations may improve interpretation of glycaemic control in the absence of standardisation across contemporary CGM systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Diagnostic Center, University Clinic for Innovative Patient Pathways, Regional Hospital Central Jutland, Silkeborg/Viborg, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Medical Department, Gødstrup Regional Hospital, Gødstrup, Denmark.
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
ORCID-Profile: Katrine Bovién Gørlitz
Zitieren
APA
Gørlitz, K. B., Heebøll, S., Fenger-Grøn, M., Fisker, S., Gregersen, S., Trolle, C., & Hansen, K. W. (2026). Differences in the Glucose Management Indicator Between Continuous Glucose Monitoring Systems. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71486
Vancouver
Gørlitz KB, Heebøll S, Fenger-Grøn M, Fisker S, Gregersen S, Trolle C, et al. Differences in the Glucose Management Indicator Between Continuous Glucose Monitoring Systems. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71486
BibTeX
@article{Grlitz2026,
author = {Gørlitz, Katrine Bovién and Heebøll, Sara and Fenger-Grøn, Morten and Fisker, Sanne and Gregersen, Søren and Trolle, Christian and Hansen, Klavs Würgler},
title = {Differences in the Glucose Management Indicator Between Continuous Glucose Monitoring Systems},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71486}
}
EUVIMED